Abstract:Redox homeostasis is crucial for the cellular viability and normal function which balance is maintained by two major cellular antioxidant systems, including glutathione system and thioredoxin system. Thioredoxin system, including thioredoxin (Trx), thioredoxin reductase (TrxR) and NADPH, exhibits a wide range of functions such as regulation of redox state and cell apoptosis. Particularly, Trx functions as a protein disulfide reductase which is essential for the function of Trx system. However, the bioactivity of Trx is closely dependent on its reducing form. According to the information, TrxR is the only cellular enzyme to catalyze the NADPH-dependent reduction of Trx. Besides the reduction of some protein disulfide like Trx, TrxR still has a broad substrate specificity to reduce some small molecules like 5, 5 '-dithiobis-2- nitrobenzoic acid (DTNB). The reduction of Trx or its own direct action towards its various substrates endows TrxR with a wide range of cellular functions. Recent studies have elucidated that TrxR was upregulated in many malignant tumors and inhibition of TrxR could prevent the tumor initiation and progression, suggesting TrxR to be a promising target for cancer therapy and the high nucleophilic and accessible selenocysteine (Sec) active site might be the prime target for drug design. Various kinds of TrxR inhibitors have been developed as anticancer agents for years. In this review, TrxR inhibitors are divided into three classes, including metal-containing inhibitors, naturally occurring products and their derivatives and other newly emerged inhibitors. The last five years reports about TrxR inhibitors of each class will be introduced and their novel inhibiting mechanisms will be discussed. Keywords: Cancer, inhibitor, thioredoxin reductase, thioredoxin system, Anticancer Agents, Redox homeostasis, NADPH, TrxR, tumor, inhibitor.

Synthesis and Molecular Recognition Studies on Small-Molecule Inhibitors for Thioredoxin Reductase

Synthesis of Naphthazarin Derivatives and Identification of Novel Thioredoxin Reductase Inhibitor As Potential Anticancer Agent

Synthesis and biological evaluation of disulfides as anticancer agents with thioredoxin inhibition

Small molecule inhibitors of mammalian thioredoxin reductase.

Targeting the Thioredoxin System for Cancer Therapy.

Recent Advances in the Development of Thioredoxin Reductase Inhibitors As Anticancer Agents

The Natural Diterpenoid Isoforretin A Inhibits Thioredoxin-1 and Triggers Potent ROS-Mediated Antitumor Effects.

3-Nitro-2h-chromenes As A New Class of Inhibitors Against Thioredoxin Reductase and Proliferation of Cancer Cells

The structure of thioredoxin and its role in the biological resistance of oxidation stress

Selenium Atom-Polarization Effect Determines TrxR-Specific Recognition of Metallodrugs.

Synthesis and Evaluation of Curcumin Analogues As Potential Thioredoxin Reductase Inhibitors

A Dual Approach to Cancer Treatment: Gold(I) Terpyridine Derivatives as DNA Binders and Inhibitors of Mammalian Thioredoxin Reductase

Cancer Therapy by Targeting Thioredoxin Reductase Based on Selenium-Containing Dynamic Covalent Bond

Broken Electron Transfer Pathway in Enzyme:Gold Clusters Inhibiting TrxR1/Trx Via Cell Studies and Theory Simulations

Thioredoxin Signaling Pathways in Cancer

Progress on Thioredoxin

Thioredoxin reductase as a pharmacological target

A Computational Insight on the Targeting of TrxR Selenocysteine

Broken electron transfer pathway in enzyme: Gold clusters inhibiting TrxR1/Trx via cell studies and theory simulations

A new gold(I) phosphine complex induces apoptosis in prostate cancer cells by increasing reactive oxygen species

Design and SAR of Withangulatin A Analogues That Act As Covalent TrxR Inhibitors Through the Michael Addition Reaction Showing Potential in Cancer Treatment.